Raphael Pharmaceutical reported net income of -$0.22M for the quarter ended Jun 2026. This income statement covers 22 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | ||||||||||||||||||||||
| Research & DevelopmentR&D | 0.22M | 0.16M | 0.22M | 0.09M | 0.08M | 0.33M | 0.68M | 0.11M | 0.29M | 0.51M | -0.35M | 0.38M | 0.02M | 0.16M | 0.21M | 0.14M | 0.04M | |||||
| Selling, General & AdministrativeSG&A | 0.16M | 0.26M | 0.35M | 0.09M | 0.53M | 1.09M | 0.43M | 0.14M | 0.13M | 0.22M | 0.27M | 0.17M | 0.23M | 0.16M | 0.18M | 0.17M | 0.16M | |||||
| Operating ExpensesOpex | 0.39M | 0.42M | 0.57M | 0.17M | 0.61M | 1.43M | 1.10M | 0.26M | 0.42M | 0.73M | -0.07M | 0.55M | 0.25M | 0.32M | 0.39M | 0.32M | 0.20M | |||||
| Operating IncomeOp. Inc | -0.39M | -0.42M | -0.57M | -0.17M | -0.61M | -1.43M | -1.10M | -0.26M | -0.42M | -0.73M | 0.13M | -0.55M | -0.25M | -0.32M | -0.39M | -0.32M | -0.20M | |||||
| EBIT | -0.39M | -0.42M | -0.57M | -0.17M | -0.61M | -1.43M | -1.10M | -0.26M | -0.42M | -0.73M | 0.13M | -0.55M | -0.25M | -0.32M | -0.39M | -0.32M | -0.20M | |||||
| Non-operating items | ||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.00M | 0.00M | 0.01M | -0.01M | -0.01M | -0.02M | 0.00M | -0.01M | 0.00M | 0.00M | -0.01M | -0.00M | 0.00M | -0.01M | -0.00M | -0.01M | -0.02M | |||||
| Net income details | ||||||||||||||||||||||
| EBT | -0.39M | -0.42M | -0.57M | -0.17M | -0.61M | -1.43M | -1.10M | -0.26M | -0.42M | -0.73M | 0.13M | -0.55M | -0.25M | -0.32M | -0.39M | -0.32M | -0.20M | |||||
| Profit After TaxPAT | -0.39M | -0.42M | -0.57M | -0.18M | -0.63M | -1.44M | -1.10M | -0.26M | -0.42M | -0.72M | 0.12M | -0.55M | -0.25M | -0.33M | -0.40M | -0.43M | -0.32M | -0.22M | ||||
| Income from Continuing OperationsIncome (Continuing) | -0.39M | -0.42M | -0.57M | -0.17M | -0.61M | -1.43M | -1.10M | -0.26M | -0.42M | -0.73M | 0.13M | -0.55M | -0.25M | -0.32M | -0.39M | -0.32M | -0.20M | |||||
| Consolidated Net IncomeConsol Net Inc. | -0.39M | -0.42M | -0.57M | -0.17M | -0.61M | -1.43M | -1.10M | -0.26M | -0.42M | -0.73M | 0.13M | -0.55M | -0.25M | -0.32M | -0.39M | -0.32M | -0.20M | |||||
| Income towards Parent CompanyParent Net Inc | -0.39M | -0.42M | -0.57M | -0.17M | -0.61M | -1.43M | -1.10M | -0.26M | -0.42M | -0.73M | 0.13M | -0.55M | -0.25M | -0.32M | -0.39M | -0.32M | -0.20M | |||||
| Net Income towards Common StockholdersNet Income | -0.39M | -0.42M | -0.57M | -0.17M | -0.61M | -1.43M | -1.10M | -0.26M | -0.42M | -0.73M | 0.13M | -0.55M | -0.25M | -0.32M | -0.39M | -0.32M | -0.20M | |||||
| Additional items | ||||||||||||||||||||||
| EPS (Basic) | -0.04 | -0.03 | -0.05 | -0.01 | -0.04 | -0.09 | -0.08 | -0.02 | -0.03 | -0.04 | 0.01 | -0.03 | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 | |||||
| EPS (Diluted) | -0.04 | -0.03 | -0.05 | -0.01 | -0.04 | -0.09 | -0.08 | -0.02 | -0.03 | -0.04 | 0.01 | -0.03 | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 | |||||
| Shares Outstanding | 10.81M | 12.13M | 11.17M | 13.04M | 13.65M | 15.06M | 14.34M | 15.96M | 16.11M | 16.44M | 16.72M | 18.62M | 18.68M | 18.70M | 18.67M | 19.63M | 19.63M | 19.63M | 19.55M | 20.18M | ||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 10.81M | 12.13M | 11.17M | 13.04M | 13.65M | 15.06M | 14.34M | 15.96M | 16.11M | 16.44M | 16.72M | 18.62M | 18.68M | 18.70M | 18.67M | 19.63M | 19.63M | 19.63M | 19.55M | 20.18M | ||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 12.05M | 12.14M | 12.97M | 13.29M | 14.23M | 15.48M | 15.62M | 16.00M | 16.37M | 18.10M | 18.50M | 18.66M | 18.70M | 18.70M | 18.70M | 19.63M | 19.63M | 19.63M | 20.18M | 20.18M | ||
| EBITDA | -0.39M | -0.42M | -0.57M | -0.17M | -0.61M | -1.43M | -1.10M | -0.26M | -0.42M | -0.73M | 0.13M | -0.55M | -0.25M | -0.32M | -0.39M | -0.32M | -0.20M |